Honokiol enhances the sensitivity of cetuximab in KRAS G13D mutant colorectal cancer through destroying SNX3-retromer complex
Theranostics · 2024
DOI: 10.7150/thno.97180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Qianru Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, China. Hauptthemen laut MEDLINE: Cetuximab, Colorectal Neoplasms, Proto-Oncogene Proteins p21(ras), Lignans. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, China.
- State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, P.R. China.
- Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
Zitieren
APA
Zhu, Q., Zhang, R., Gu, X., Zhao, Z., Gao, Q., Chen, M., Wu, Q., Xie, T., & Sui, X. (2024). Honokiol enhances the sensitivity of cetuximab in KRAS G13D mutant colorectal cancer through destroying SNX3-retromer complex. Theranostics. https://doi.org/10.7150/thno.97180
Vancouver
Zhu Q, Zhang R, Gu X, Zhao Z, Gao Q, Chen M, et al. Honokiol enhances the sensitivity of cetuximab in KRAS G13D mutant colorectal cancer through destroying SNX3-retromer complex. Theranostics. 2024. doi:10.7150/thno.97180
BibTeX
@article{Zhu2024,
author = {Zhu, Qianru and Zhang, Ruonan and Gu, Xiaoqing and Zhao, Ziming and Gao, Quan and Chen, Min and Wu, Qibiao and Xie, Tian and Sui, Xinbing},
title = {Honokiol enhances the sensitivity of cetuximab in KRAS G13D mutant colorectal cancer through destroying SNX3-retromer complex},
journal = {Theranostics},
year = {2024},
doi = {10.7150/thno.97180}
}
EUVIMED